Reusable surgical instruments: a market being reshaped
The MDR and the push for greener healthcare are changing Europe's instrument market at the same time. For manufacturers, importers, brands, procedure-pack producers and hospitals that act early, this is a real opportunity. We help you see where you stand, choose your route and get it done.
Portfolios are being reviewed. The first movers win.
Under the MDR, reusable surgical instruments (Class Ir) need a notified body to assess their reprocessing. Single-use instruments are medical devices too — often in a higher class than expected — and a procedure pack is only as compliant as every instrument in it. Across Europe, portfolios are now being reviewed: what continues, what changes, what stops.
At the same time, hospitals are under pressure to cut waste. Reusable instruments are part of the answer — but only if they stay available and compliant.
- Secure your portfoliobefore competitors do, and become the reliable choice for buyers.
- Replace what's at riskwith qualified alternatives, while others are still searching.
- Choose between reusable and single-usebased on the facts: cost, classification, reprocessing and user preference.
- Help hospitals meet their green targetswith reusable solutions, including in procedure packs, where workflow and total cost add up.
- 26 May 2027 — UDI on the instrument itselfReusable Class I instruments placed on the market under the MDR must, in principle, carry their UDI directly on the instrument.
- 31 December 2028 — end of legacyFrom then on, legacy instruments can only be placed on the market with an MDR certificate — and only if the transition conditions were met in 2024. Notified-body capacity takes planning.
- Private label — your name, your responsibilitySelling under your own name can make you the legal manufacturer.
We check. We don't assume.
A catalogue or a registration alone proves little. For every product that matters, we look at the label and UDI, the EU declaration of conformity, the reprocessing instructions and — for Class Ir — the notified-body certificate and its scope. That's how you get conclusions you can act on.
For everyone in the chain
Manufacturers
Inside and outside the EU: choose your route to Europe and keep the evidence your customers ask for up to date.
Importers, distributors & brands
Know which product families are at risk before it affects your sales.
Procedure-pack producers
Keep track of the status of, and changes to, every instrument in your packs.
Hospitals & purchasers
Ask the right questions and spot supply risks early.
Start small, decide fast, grow together
Portfolio Continuity Scan
For each product family: manufacturer, registrations, certificates and scope, economic-operator roles, labelling and supplier dependencies. You get priorities and decision points — as a one-off scan or ongoing monitoring.
Product Continuity Route
One product family at risk? We compare your options — continue, remediate, replace, change roles or phase out — and make the chosen route happen. Not a referral, but a decision you can act on.
Partnering for the long term
From managing your technical documentation to taking on a formal role in your European supply chain — wherever governance, control and commitment are right on both sides.
Making, importing or buying reusable instruments for Europe?
Let's look at your portfolio together — directly with the founders.
Start with a portfolio scan